Pixilab
Home › Companies › Biotechnology, Health Diagnostics, Hospital, Medical, Oncology › Isabl Inc.

Isabl Inc.

Isabl develops cancer diagnostic tests based on whole genome and RNA sequencing data.

Isabl Inc. is active in the biotechnology, health diagnostics, hospital, medical, oncology space based in Greater New York Area, East Coast, Northeastern US, founded in 2020.

The company sits in the biotechnology, health diagnostics, hospital, medical, oncology segment, where it competes on its core product or service.

Its base of operations is Greater New York Area, East Coast, Northeastern US.

The company is listed at the Grant stage of development.

Recorded headcount: c_00001_00010 employees.

Total disclosed funding stands at about $5M.

SectorBiotechnology, Health Diagnostics, Hospital, Medical, Oncology
HeadquartersGreater New York Area, East Coast, Northeastern US
CountryUNITED STATES
Founded2020
Employeesc_00001_00010
Stagegrant
Total funding$5,000,000

Website: www.isabl.com

Browse related

More Biotechnology, Health Diagnostics, Hospital, Medical, Oncology companies Companies in UNITED STATES Companies founded in 2020
Emails and contact routes are reserved for registered members.
Create a free account